Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000152784 | SCV000202172 | benign | not specified | 2015-02-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000266611 | SCV001100676 | benign | Muscle AMP deaminase deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002510793 | SCV002821412 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | AMPD1: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV002510793 | SCV005280459 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003917486 | SCV004733854 | benign | AMPD1-related disorder | 2022-03-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |